These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 3193607)

  • 41. Basic issues in population screening for cancer.
    Cole P; Morrison AS
    J Natl Cancer Inst; 1980 May; 64(5):1263-72. PubMed ID: 6767876
    [TBL] [Abstract][Full Text] [Related]  

  • 42. "Just Another Statistic".
    Machtay M; Glatstein E
    Oncologist; 1998; 3(3):III-IV. PubMed ID: 10388105
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Population estimates of survival in women with screen-detected and symptomatic breast cancer taking account of lead time and length bias.
    Lawrence G; Wallis M; Allgood P; Nagtegaal ID; Warwick J; Cafferty FH; Houssami N; Kearins O; Tappenden N; O'Sullivan E; Duffy SW
    Breast Cancer Res Treat; 2009 Jul; 116(1):179-85. PubMed ID: 18622697
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Secondary prevention: screening for breast cancer.
    Chamberlain J
    Eff Health Care; 1985; 2(5):179-88. PubMed ID: 10271344
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Problems in using survival data of cancer patients as a method of gauging the effectiveness of cancer control efforts].
    Oshima A
    Gan No Rinsho; 1988 Oct; 34(12):1637-41. PubMed ID: 3193607
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cancer screening: the clash of science and intuition.
    Kramer BS; Croswell JM
    Annu Rev Med; 2009; 60():125-37. PubMed ID: 18803476
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Progress in cancer control in Wisconsin.
    Quenan L; Remington P
    WMJ; 2000 Jun; 99(3):34-8. PubMed ID: 10927979
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Reducing the effects of lead-time bias, length bias and over-detection in evaluating screening mammography: a censored bivariate data approach.
    Mahnken JD; Chan W; Freeman DH; Freeman JL
    Stat Methods Med Res; 2008 Dec; 17(6):643-63. PubMed ID: 18445697
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Detection of prostate cancer: the impact of the European Randomized Study of Screening for Prostate Cancer (ERSPC).
    Schröder FH
    Can J Urol; 2005 Feb; 12 Suppl 1():2-6; discussion 92-3. PubMed ID: 15780157
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The science of early detection.
    Kramer BS
    Urol Oncol; 2004; 22(4):344-7. PubMed ID: 15283894
    [TBL] [Abstract][Full Text] [Related]  

  • 51.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 52.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 53.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 54.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 3.